Lynn Newbould

Lynn Newbould is a clinical development, strategic sourcing professional with
more than 25 years of experience supporting prominent sponsors in the
pharmaceutical and biotech industry with their CRO strategy development,
supplier selections, vendor and alliance management as well as contract and
budget negotiations. In her current role at Alnylam Pharmaceuticals, a leader
in the translation of RNA interference into a new class of medicines, she is a
member of the CRO governance team, chairs the Clinical Development
Sounding Board and manages her team in supporting the sourcing needs for
the clinical development plan.

Lynn earned her BA from Lehigh University and MBA from Penn State University.